期刊文献+

奥沙利铂化学治疗致神经毒性反应的综合护理体会 被引量:4

下载PDF
导出
摘要 目的探讨奥沙利铂化学治疗后致神经毒性不良反应的护理。方法对27例奥沙利铂化学治疗后产生神经毒性不良反应的患者进行有效综合护理,以减轻患者痛苦,提高患者生存质量,促进患者痊愈。结果 27例患者中,神经毒性1级为19例,2级为5例,3级为3例,均通过治疗护理后恢复,化学治疗方案完成后均顺利出院。结论良好的治疗加上积极、全面、有效的护理,能有效降低患者化学治疗致神经毒性反应的发生率,缓解患者痛苦,提高生存质量。
作者 陈慧芳
出处 《中国药业》 CAS 2013年第5期118-118,共1页 China Pharmaceuticals
  • 相关文献

参考文献6

二级参考文献15

  • 1段小芳.护理干预对减缓奥沙利铂化疗后毒副作用的体会[J].湖南中医杂志,2005,21(3):107-108. 被引量:19
  • 2胡雁.正确认识循证护理 推动护理实践发展[J].中华护理杂志,2005,40(9):714-717. 被引量:281
  • 3Gamelin E, Gamelin L, Bossi L, et al. Clinical aspects and molecularbasis of oxaliplatin neurotoxicity: current management and development of preventive measures[J]. Semin Oneol, 2002, 29(5 Suppl I5): 21 - 33.
  • 4Kouvaris JR, Kouloulias VE, Vlahos LJ. Amifostine the first selective- target and broad - spectrum radioprotector [ J ]. Oncologist. 2007, 12 (6) : 738 - 747.
  • 5Gamelin L, Boisdron - Celle M, Delva R. et al. Prevention of oxalipatin - related neurotoxicity bv calcium and magnesium infusions: a restrn-spective study of 161 patients receiving oxaliplatin combined with 5- fluorouracil and leucovorin for advanced colorectal cancer[J]. Clin Can- cer Res. 2004.10(12 Pt 1):4055 -4061.
  • 6Kelly H, Goldberg RM. Systemic therapy for metastatic colorectal cancer current options, current evidence[J]. Clin Oncol, 2005, 23(12): 4 553 - 4 590.
  • 7Cassidy J, Misset JL. Oxaliplatin- related side effects:Characteristics and management [ J ]. Semin Oneol, 2002, 29 (5 Suppl 15 ) : 11 - 20.
  • 8Grothey A. Clinical management of oxaliplatin- associated neurotox city [J]. Clin Colorectal Cancer, 2005,5(Suppl 1): S 38 - 46.
  • 9Culy CR, Spencer CM. Amifostine, an update on its clinical status as a cytoprotectant in patients with cancer receiving chemotherapy and ra- diotherapy and its potential therapeutic application in myelodysplastic syndrome [ J ]. Drugs, 2001,61 (5) : 641 - 648.
  • 10Verstappen CC, Postma T J, Geldof AA, et al. Amifostine protects against chemotherapy-induced neurotoxicitv: an in vitro investigation[J] .Anti- cancer Res, 2004, 24(4): 2 337 - 2 341.

共引文献27

同被引文献29

  • 1Levi F,Misset JL, Brienza S, et al. A chronopharmacologic phase II clinical trial with 5-fluorouracil, falinic acid, and oxaliplatinusing an ambulatory multichannel programmable pump. High antitumor effectiveness against metastatic colorectal cancer [ J ]. Cancer, 1992,69 (4) :893-900.
  • 2Wang X J, Li YY, Luo L, et al. Oxaliplatin activates the Keapl/Nrf2 an- tioxidant system conferring protection against the cytotoxieity of anticancer drugs [J]. Free Radical Biology and Medicine, 2014,70:68 - 77.
  • 3Langer C J, Novello S, Park K, et al. Randomized, phase III trial of first- line figitumumab in combination with paclitaxel and carboplatin versus paclitaxel and carboplatin alone in patients with advanced non- small - cell lung cancer[J]. J Clin 0ncol,2014,32(19): 2 059 - 2 066.
  • 4王建荣.输液治疗护理实践指南与实施细则主编[M].北京:人民军医出版社,2012,3:123.
  • 5余薇,程玉兰,吴莉莉.喜辽妥防治奥沙利铂所致静脉炎的效果观察[J].医药前沿,2013,价239.
  • 6吴红黎.1例奥沙利铂化疗药外滲的护理[J].中外健康文摘,2012,12(01):282.
  • 7沈焕云.氟尿嘧啶联合奥沙利铂治疗晚期大肠癌的护理体会[J].护理实践与研究,2010,7(3):49-51. 被引量:13
  • 8陈婉玲,曾波航,潘珊,李宇清,王碧幸,陈丽琴.姑息性化疗对中晚期肺癌患者生存状态的影响[J].广东医学,2010,31(11):1405-1407. 被引量:17
  • 9徐永琼,吴敏.2种不输液途径对奥沙利铂化疗患者神经毒性的影响[J].中华现代护理杂志,2010,16(14):1650-1651. 被引量:9
  • 10张翠敏,朱贵东,肖永红.女性肺癌患者生存质量评价及影响因素分析[J].临床肺科杂志,2011,16(1):78-80. 被引量:11

引证文献4

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部